Fosamax Ruling Puts Preemption In Play For Branded Drugs
A New Jersey federal judge's ruling Thursday that claims related to Merck & Co. Inc.'s Fosamax are preempted by federal law will likely inspire other brand-name drug makers to mount the...To view the full article, register now.
Already a subscriber? Click here to view full article